Defiance China Memory ETF
CRAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$563.46M
Close$
Share Statistics
| Market cap | $563.46 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Portfolio Building Block World Pharma and Biotech Index ETF
CEO: Charles Alan Ragauss The Fund seeks to track, before fees and expenses, the performance of the BITA World Pharma and Biotech Index, which includes global pharmaceutical and biotechnology companies.